{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:02:16Z","timestamp":1785391336350,"version":"3.55.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated the clinical and electrodiagnostic features of vasculitic peripheral neuropathy (VPN) in symptomatic patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who underwent nerve conduction studies (NCS) within 3 months after AAV diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Among 323 patients with AAV, 97 presenting with clinical symptoms suggestive of VPN and with the availability of results of NCS performed within 3 months after AAV diagnosis were included in this study. VPN was classified based on the case definition and guidelines proposed by the Brighton Collaboration Vasculitic Peripheral Neuropathy Working Group in 2017. Of the 97 patients, 12 underwent nerve biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At AAV diagnosis, the median age of the 97 patients was 63.0 years (57% women), consisting of 48 patients with microscopic polyangiitis (MPA), 20 with granulomatosis with polyangiitis (GPA), and 29 with eosinophilic granulomatosis with polyangiitis (EGPA). Among symptomatic AAV patients who underwent early NCS, 55 patients (56.7%) were classified as having electrodiagnostically supported VPN. The most common type of VPN was a mixed type (83.6%), and the most frequently affected nerve was the peroneal nerve (70.9%). The concordance rate between NCS and nerve biopsy findings was 75% based on histological evidence of vasculitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this selected cohort of symptomatic AAV patients who underwent NCS within 3 months after diagnosis, more than half were classified as having electrodiagnostically supported VPN. NCS may provide adjunctive objective information for characterizing peripheral nerve involvement in clinically suspected VPN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1807774","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:28Z","timestamp":1785389968000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and electrodiagnostic features of nerve conduction study-classified peripheral neuropathy in symptomatic patients with antineutrophil cytoplasmic antibody-associated vasculitis: a single-centre cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Jang Woo","family":"Ha","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine","place":["Yongin, Gyeonggi-do, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Chan","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]},{"name":"Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]},{"name":"Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American college of rheumatology\/European alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2022.0435","article-title":"Comparison of the 2022 ACR\/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria","volume":"64","author":"Pyo","year":"2023","journal-title":"Yonsei Med J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.123","article-title":"ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients","volume":"12","author":"Cornec","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.051078","article-title":"Development of comprehensive disease assessment in systemic vasculitis","volume":"66","author":"Flossmann","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203255","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group","volume":"72","author":"Millet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152751","article-title":"Nervous system involvement in ANCA-associated vasculitis: Single center experience from Latin America","volume":"73","author":"Quintero-Giraldo","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.047","article-title":"Vasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data","volume":"35","author":"Hadden","year":"2017","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2010.00281.x","article-title":"Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary","volume":"15","author":"Collins","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"B15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14737175.2018.1489240","article-title":"Value of nerve biopsy in the management of peripheral neuropathies","volume":"18","author":"Mathis","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64032-1.00014-X","article-title":"Nerve conduction studies: Basic concepts","volume":"160","author":"Tavee","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.ncl.2021.06.002","article-title":"Nerve conduction studies: basic concepts and patterns of abnormalities","volume":"39","author":"O'Bryan","year":"2021","journal-title":"Neurol Clin"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1179\/1476830513Y.0000000073","article-title":"Clinical, nerve conduction and nerve biopsy study in vitamin B12 deficiency neurological syndrome with a short-term follow-up","volume":"17","author":"Kalita","year":"2014","journal-title":"Nutr Neurosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1694747","article-title":"A clinician's approach to peripheral neuropathy","volume":"39","author":"Siao","year":"2019","journal-title":"Semin Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27086","article-title":"Metabolic syndrome and peripheral neuropathy","volume":"63","author":"Kazamel","year":"2021","journal-title":"Muscle Nerve"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000985","article-title":"Serial nerve conduction studies in Guillain-Barr\u00e9 syndrome: its usefulness and precise timing","volume":"41","author":"Lee","year":"2024","journal-title":"J Clin Neurophysiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker266","article-title":"Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials","volume":"50","author":"Suppiah","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000615","article-title":"Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study","volume":"6","author":"Bischof","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_47_18","article-title":"Vasculitic neuropathy: A retrospective analysis of nerve biopsies and clinical features from a single tertiary care center","volume":"22","author":"Hui","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.2013.13805","article-title":"The state of US health, 1990-2010: burden of diseases, injuries, and risk factors","volume":"310","author":"Murray","year":"2013","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1078\/0171-2985-00200","article-title":"Effective B cell depletion with rituximab in the treatment of autoimmune diseases","volume":"206","author":"Kneitz","year":"2002","journal-title":"Immunobiology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1807774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:39:30Z","timestamp":1785389970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1807774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1807774"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1807774","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1807774"}}